Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan H King

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
CNS Spectrums|March 6, 2004
Impact of recent findings on study design of future autism clinical trialsEric Hollander, Ann Phillips, Bryan H King, et al.
Journal of Child and Adolescent Psychopharmacology|May 3, 2022
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive BehaviorsEmily Simonoff, Florence Mowlem, Oliver Pearson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2016
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 TrialJeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, et al.
Autism : the International Journal of Research and Practice|October 12, 2013
Training of child and adolescent psychiatry fellows in autism and intellectual disabilityNatasha Marrus, Jeremy Veenstra-Vanderweele, Jessica A Hellings, et al.
CNS Spectrums|March 6, 2004
Outcome measures for clinical drug trials in autismMichael G Aman, Sherie Novotny, Carole Samango-Sprouse, et al.
Pediatric Neurology|December 24, 2014
Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND ChecklistPetrus J de Vries, Vicky H Whittemore, Loren Leclezio, et al.
JAMA Pediatrics|September 25, 2013
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trialBryan H King, Kimberly Dukes, Craig L Donnelly, et al.
Contemporary Clinical Trials|August 11, 2020
Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B)Marina Spanos, Tara Chandrasekhar, Soo-Jeong Kim, et al.
Archives of General Psychiatry|June 3, 2009
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autismBryan H King, Eric Hollander, Linmarie Sikich, et al.
Frontiers in Pediatrics|May 13, 2022
Adolescents With Eating Disorders in Pediatric Practice - The European Academy of Paediatrics RecommendationsAgnieszka Rynkiewicz, Łukasz Dembiński, Berthold Koletzko, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
CNS Spectrums|March 6, 2004
Impact of recent findings on study design of future autism clinical trialsEric Hollander, Ann Phillips, Bryan H King, et al.
Journal of Child and Adolescent Psychopharmacology|May 3, 2022
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive BehaviorsEmily Simonoff, Florence Mowlem, Oliver Pearson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2016
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 TrialJeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, et al.
Autism : the International Journal of Research and Practice|October 12, 2013
Training of child and adolescent psychiatry fellows in autism and intellectual disabilityNatasha Marrus, Jeremy Veenstra-Vanderweele, Jessica A Hellings, et al.
CNS Spectrums|March 6, 2004
Outcome measures for clinical drug trials in autismMichael G Aman, Sherie Novotny, Carole Samango-Sprouse, et al.
Pediatric Neurology|December 24, 2014
Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND ChecklistPetrus J de Vries, Vicky H Whittemore, Loren Leclezio, et al.
JAMA Pediatrics|September 25, 2013
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trialBryan H King, Kimberly Dukes, Craig L Donnelly, et al.
Contemporary Clinical Trials|August 11, 2020
Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B)Marina Spanos, Tara Chandrasekhar, Soo-Jeong Kim, et al.
Archives of General Psychiatry|June 3, 2009
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autismBryan H King, Eric Hollander, Linmarie Sikich, et al.
Frontiers in Pediatrics|May 13, 2022
Adolescents With Eating Disorders in Pediatric Practice - The European Academy of Paediatrics RecommendationsAgnieszka Rynkiewicz, Łukasz Dembiński, Berthold Koletzko, et al.
Pageof 6